Dry Age-Related Macular Degeneration Pharmacology.

about

RS9, a novel Nrf2 activator, attenuates light-induced death of cells of photoreceptor cells and Müller glia cells.Delivery of CR2-fH Using AAV Vector Therapy as Treatment Strategy in the Mouse Model of Choroidal Neovascularization.

P2860

Q38710437-B76FBDA7-E10A-4866-9D73-546A5C6500A9 Q45875770-0E2E4944-19AE-4752-A991-B4F0DF102AD4

P2860

Dry Age-Related Macular Degeneration Pharmacology.

Item

http://www.wikidata.org/entity/Q38789140

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Dry Age-Related Macular Degeneration Pharmacology.

@en

type

Item

label

Dry Age-Related Macular Degeneration Pharmacology.

@en

prefLabel

Dry Age-Related Macular Degeneration Pharmacology.

@en

P1476

Dry Age-Related Macular Degeneration Pharmacology.

@en

P2093

Charles B Wright

http://www.w3.org/2001/XMLSchema#string

Jayakrishna Ambati

http://www.w3.org/2001/XMLSchema#string

P2860

Ginkgo biloba extract for age-related macular degeneration

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8

Complement factor H polymorphism in age-related macular degeneration

DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88

Geographic atrophy in patients with advanced dry age-related macular degeneration: current challenges and future prospects

Tapping Stem Cells to Target AMD: Challenges and Prospects

Mechanisms of age-related macular degeneration

Systemic administration of Abeta mAb reduces retinal deposition of Abeta and activated complement C3 in age-related macular degeneration mouse model

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

Recent developments in the management of dry age-related macular degeneration

P304

321-336

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/164_2016_36

http://www.w3.org/2001/XMLSchema#string

P478

242

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27900609

http://www.w3.org/2001/XMLSchema#string

P932

5472449

http://www.w3.org/2001/XMLSchema#string

Dry Age-Related Macular Degeneration Pharmacology.

about

P2860

P2860

Dry Age-Related Macular Degeneration Pharmacology.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932